China Universal Asset Management Company’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Buy |
32,167
+2,264
| +8% | +$10.6K | 0.01% | 334 |
|
|
2025
Q1 | $164K | Sell |
29,903
-1,708
| -5% | -$9.38K | 0.02% | 327 |
|
|
2024
Q4 | $107K | Buy |
31,611
+2,954
| +10% | +$10K | 0.01% | 384 |
|
|
2024
Q3 | $81.7K | Buy |
28,657
+11,239
| +65% | +$32K | 0.01% | 369 |
|
|
2024
Q2 | $39.2K | Sell |
17,418
-9,098
| -34% | -$20.5K | 0.01% | 371 |
|
|
2024
Q1 | $58.6K | Buy |
26,516
+10,543
| +66% | +$23.3K | 0.01% | 407 |
|
|
2023
Q4 | $37.5K | Buy |
15,973
+12,432
| +351% | +$29.2K | 0.01% | 393 |
|
|
2023
Q3 | $6.59K | Buy |
3,541
+1,742
| +97% | +$3.24K | ﹤0.01% | 371 |
|
|
2023
Q2 | $4.71K | Sell |
1,799
-43
| -2% | -$113 | ﹤0.01% | 377 |
|
|
2023
Q1 | $3K | Buy |
1,842
+461
| +33% | +$751 | ﹤0.01% | 412 |
|
|
2022
Q4 | $1.84K | Buy |
1,381
+108
| +8% | +$144 | ﹤0.01% | 378 |
|
|
2022
Q3 | $2K | Buy |
+1,273
| New | +$2K | ﹤0.01% | 362 |
|